College of American Pathologists
CAP Committees & Leadership CAP Calendar of Events Estore CAP Media Center CAP Foundation
 
About CAP    Career Center    Contact Us      
Search: Search
  [Advanced Search]  
 
CAP Home CAP Advocacy CAP Reference Resources and Publications CAP Education Programs CAP Accreditation and Laboratory Improvement CAP Members
CAP Home > CAP TODAY > 2011 CAP TODAY Article Index

  2012 CAP TODAY Article Index

 

Cap Today

Note: This index does not cover the CAP TODAY “Marketplace” or “Abstracts” columns.

AACC meetings
Lab science takes center stage at AACC 2012, 09/12:72

Accountable care organizations (ACOs)
To create ACO success, get all players aligned, 09/12:5

AIDS/HIV/other blood borne diseases
In new HIV guideline, 20+ years of change, 03/12:1

American Board of Pathology
ABP on voluntary recertification, MOC reporting, 06/12:64

Analyzers (see Instrumentation/instrument product guides)

Anatomic pathology
AP IT—a bigger roof and beyond the walls, 03/12:1
Partnering to waltz AP IT into next generation, 04/12:42

Antiviral drug testing resistance
Flu, HSV: testing for antiviral resistance, 06/12:1

Automation
New fixes, configurations in automation solutions, 02/12:12

Best practices
Small start, then big drop in specimen labeling errors, 07/12:107

Billing/revenue cycle management
A look at the latest in laboratory billing systems, 08/12:18

Biorepositories
CAP takes the reins on biorepository accreditation, 10/12:5

Biotechnology
By Zeus! Prometheus ruling checks patents, 06/12:1

Blood/coagulation/hematology
Needlestick patrol: breaking bad habits, 01/12:1
‘Elders’ hang tough against newcomers, 01/12:1
From the new to the improved, 01/12:19
Bantam cell guide packs heavyweight punch, 06/12:80
As coag tests evolve, so do checklist requirements, 11/12:67
In hematology, greater automation and further standardization, 12/12:18

Blood banking/transfusion
Slowing the flow in blood Tx, 09/12:1
Vendors break down business of blood bank systems, 09/12:12

Bone marrow collection/biopsies
Dodging bone marrow’s many disguises, 02/12:1

Breast cancer/breast health
AP, radiology talk it out on breast cancer cases, 08/12:50
On lumpectomy surgical margins, a push for clarity, 10/12:1

Business intelligence software
Here and now, business software tracks lab labors, 06/12:3

Cancer (see also Leukemia)
Optional vs. required and more—putting protocols into practice, 02/12:44
Hows and whys behind updated cancer protocols, 03/12:5
Evaluating a sample for an acute leukemia, 04/12:62
Mixed phenotype acute leukemia—case presentation, 04/12:66
With paraneoplastic syndromes, big riddle from hidden tumors, 05/12:1
With AML genetic profiling, it takes all kinds, 06/12:1
At LAST, one HPV diagnostic terminology, 07/12:1
New guidelines could jump-start hrHPV testing, 07/12:70
Finding a clinical fit for next-gen sequencing, 09/12:1
On lumpectomy surgical margins, a push for clarity, 10/12:1
Group puts cancer cytogenomic arrays through their paces, 11/12:1

CAP ’11 meeting
Dodging bone marrow’s many disguises, 02/12:1
For pathologists, a one-stop shop for learning, 02/12:85

CAP accreditation/checklists/protocols
Optional vs. required and more—putting protocols into practice, 02/12:44
Hows and whys behind updated cancer protocols, 03/12:5
CAP takes the reins on biorepository accreditation, 10/12:5
As coag tests evolve, so do checklist requirements, 11/12:67
Accreditation beyond U.S.? ‘Nothing impossible’ about it, 12/12:46

CAP Foundation
Pathology outreach in three words—see, test, treat, 03/12:66
CAP and its Foundation honor 23, 10/12:84

CAP Press
Providing consults in support of the pain service, 01/12:66
Evaluating a sample for an acute leukemia, 04/12:62
Mixed phenotype acute leukemia—case presentation, 04/12:66
Bantam cell guide packs heavyweight punch, 06/12:80

CAP programs/products/services (see also Q-Probes and Proficiency testing)
3 measures beckon more pathologists into PQRS tent, 01/12:3
Glucose to Gram stain—new competency tests for 2012, 01/12:64
For pathologists, a one-stop shop for learning, 02/12:85
LAP at 50—ups, downs, and ‘round the world, 03/12:54
Pathology outreach in three words—see, test, treat, 03/12:66
Bringing down defects in surgical pathology reports, 05/12:3
For new analytes, expanded PT exchange, 05/12:66
Specimen rejection: What price for patient care?, 07/12:5
CAP leads way with next-gen checklist, 08/12:1
In RN Q-Probes, no room for complacency, 11/12:54
On complex surg path, how do lab TATs compare? 12/12:5

Cardiovascular disease/cardiac markers
To see troponin’s future, look at the present, 07/12:1

Celiac disease
Celiac disease testing—sifting through the options, 10/12:40

Chemistry testing (see also Immunohistochemistry)
Low-volume analyzers: growing menus, more consolidation, 10/12:12

CLSI (formerly NCCLS)
In new HIV guideline, 20+ years of change, 03/12:1

Coagulation (see Blood/coagulation/hematology)

Co-mingling of radiology and pathology (see also Radiology)
AP, radiology talk it out on breast cancer cases, 08/12:50

Companion diagnostics
Two for the road with companion diagnostics, 04/12:1

CPT questions/coding
88305 TC cut, molecular code decision, PQRS details, 11/12:3

Creatinine
Cystatin C and creatinine—using both found to be best, 09/12:58
Latest study could prompt wider use of CKD-EPI equation, 10/12:1

Cytopathology and More
Approved assays for detecting HPV DNA—design, indications, and validation, 01/12:40
Critical values and diagnoses, with emphasis on cytopathology, 01/12:45
Fields of View online—what it is, how it works, 01/12:48
Cytopathology of pulmonary infections, 05/12:50
Excluding specimens from cytologic review, 05/12:52
Can we protect our images in a digital world?, 05/12:54
A webinar on regs, surveys, deficiencies, 05/12:56
New screening guidelines—order amid complexity, 08/12:42
My life as glass: ‘I was great and gorgeous’, 08/12:42

Digital pathology/digital imaging/computer-assisted imaging
Regulators scanning the digital scanners, 01/12:1
AP IT—a bigger roof and beyond the walls, 03/12:1

Drugs of abuse
Tricks and traps of testing for benzos and barbs, 02/11:64

Editorials of CAP president (see From the President’s Desk)

Electronic health/medical records (EHR/EMR)
LPL software companies plug the gaps, hold their own, 04/12:3
LIS, EHR tying the knot, 11/12:1

EMR donations
On EMR donations, steer clear of troubled waters, 08/12:70

Estimated glomerular filtration rate (eGFR) (see Kidney disease)
Cystatin C and creatinine—using both found to be best, 09/12:58
Latest study could prompt wider use of CKD-EPI equation, 10/12:1

Executive War College
On EMR donations, steer clear of troubled waters, 08/12:70
In face of threats, time for labs to seize the day, 09/12:36

From the President’s Desk
Center’s work reflects Hamilton legacy, 01/12:11
The DigitalScope experience, 02/12:11
Promoting excellence far from home, 03/12:11
CAP learning portal opens doors, 04/12:11
Evidence points to ending the exception, 05/12:11
Core of prime program: communication, 06/12:11
LAST project launches new era, 07/12:11
See, Test and Treat needs your support, 08/12:11
For safety, generations of volunteers, 09/12:11
A parade of learning options, 10/12:11
For pathology, promising new steps, 11/12:9
New solutions to ease PT, practice demands, 12/12:11

Genetics/genetic testing (see also Next-generation sequencing)
In genetic testing, decoding the enigma variants, 01/12:32
With AML genetic profiling, it takes all kinds, 06/12:1

Genomics
New attention settling on genomic thyroid nodule test, 11/12:39
Fixing FFPE specimens for genomic age, 12/12:1

Human chorionic gonadotropin
Not so obvious—ifs, whens, hows of hCG testing, 06/11:26

Human papillomavirus
At LAST, one HPV diagnostic terminology, 07/12:1
New guidelines could jump-start hrHPV testing, 07/12:70

Infection control
Lowering infectious disease risks for transplants, 10/12:32

Infectious disease surveillance/testing
More or less—MRSA vigils, TATs, costs, 05/12:1

Information systems, software technologies (see also Automation)
In middleware, expert rules use marches on, 02/12:1
Middleware systems, 02/12:58
AP IT—a bigger roof and beyond the walls, 03/12:1
Anatomic pathology computer systems, 03/12:21
LPL software companies plug the gaps, hold their own, 04/12:3
Partnering to waltz AP IT into next generation, 04/12:42
Laboratory-provider links software, 04/12:71
Finally, microbiology labs getting a lift from IT, 05/12:32
Positive patient ID: party of one or more?, 07/12:1
Tightening the reins on positive patient ID, 07/12:98
Positive patient identification products, 7/12:100
A look at the latest in laboratory billing systems, 08/12:18
Vendors break down business of blood bank systems, 09/12:12
Blood bank information systems, 09/12:16
LIS, EHR tying the knot, 11/12:1
Laboratory information systems, 11/12:21

Instrumentation/instrument product guides
From the new to the improved, 01/12:19
New fixes, configurations in automation solutions, 02/12:12
Bedside glucose testing systems, 04/12:22
Safety at the point of care, 04/12:22
Coagulation analyzers—point of care, self-monitoring, 05/12:20
For POC coag, direct clot-detection technology, new quality features, Ensemble software, 05/12:20
Finally, microbiology labs getting a lift from IT, 05/12:32
Chemistry analyzers for mid- and high-volume laboratories, 06/12:32
Delivering lean, green, fast, and flexible, 06/12:32
Immunoassay analyzers: here and on the horizon, 07/12:14
Automated immunoassay analyzers, 07/12:18
Blood gas analyzers: retooled designs, more choices, 08/12:75
In vitro blood gas analyzers, 08/12:76
Next-generation sequencing instruments, 09/12:50
Low-volume analyzers: growing menus, more consolidation, 10/12:12
Chemistry analyzers (for low-volume laboratories), 10/12:13
Automated molecular platforms, 10/12:54
In hematology, greater automation and further standardization, 12/12:18
Hematology analyzers, 12/12:20

Insurance companies/issues
In face of threats, time for labs to seize the day, 09/12:36

Kidney disease/kidney injury (see also Estimated glomerular filtration rate)
Cystatin C and creatinine—using both found to be best, 09/12:58
Latest study could prompt wider use of CKD-EPI equation, 10/12:1

Laboratory efficiency/cost-savings measures
From bottom to top, a culture of safety, 03/12:1
For productivity gains, histology labs press on, 09/12:1

Laboratory outreach
Future of lab outreach: all systems go, 08/12:1

Lean manufacturing principles/Six Sigma (see also Laboratory efficiency/cost-savings measures)
Ducks now all in a row in Lean flow cytometry lab, 01/12:50
For productivity gains, histology labs press on, 09/12:1

Legal issues/actions (see also Medical mistakes)
By Zeus! Prometheus ruling checks patents, 06/12:1

Letters
Cobas BRAF V600 mutation test and Zelboraf, 02/12:8
EPCA-2 marker for prostate cancer, 03/12:8
Comparing APTT reagents, 04/12:8
Performance measures, 04/12:8
Laboratory Accreditation Program memories, 05/12:11
Contaminated blood cultures, 06/12:11
Self-referral, 09/12:8
HPV diagnostic terminology, 09/12:8
Positive patient ID, 09/12:11
Next-gen requirements, 09/12:11
See, Test and Treat program, 10/12:12

Leukemia
Evaluating a sample for an acute leukemia, 04/12:62
With AML genetic profiling, it takes all kinds, 06/12:1

Medical mistakes (see also Legal issues/actions)
Bringing down defects in surgical pathology reports, 05/12:3
Small start, then big drop in specimen labeling errors, 07/12:107

Medicare/Medicaid
3 measures beckon more pathologists into PQRS tent, 01/12:3
Negotiating TC payment in wake of grandfather vote, 07/12:88
88305 TC cut, molecular code decision, PQRS details, 11/12:3

Microbiology
Finally, microbiology labs getting a lift from IT, 05/12:32

Microbiome
Microbiome—‘second genome’ and medicine’s next frontier, 02/12:5

Middleware
In middleware, expert rules use marches on, 02/12:1

Molecular diagnostics (see also Polymerase chain reaction [PCR] technology)
Flu, HSV: testing for antiviral resistance, 06/12:1
Small lab? Try thinking big on molecular, 11/12:1
Fixing FFPE specimens for genomic age, 12/12:1

Molecular pathology
For respiratory virus detection, a golden age, 04/12:1
For molecular menus, dynamic choices, 10/12:1

MRSA screening/infection
More or less—MRSA vigils, TATs, costs, 05/12:1

Myocardial infarction (see Cardiovascular disease/cardiac markers)

National patient identifier/VUHID
VUHID validated, but patient identification system progressing slowly, 12/12:71

Needlestick injuries
Needlestick patrol: breaking bad habits, 01/12:1

Newsbytes
Foundation to pilot test standard for lab orders, 01/12:81
Siemens Healthcare acquires MobileMD, 01/12:81
McKesson undertaking new marketing strategy, 01/12:81
Siemens lab system a winner in 2011 Best in KLAS Awards, 01/12:81
Contracts, 01/12:81
Meditech morphing into EMR vendor but not leaving the lab, 02/12:95
New laboratory informatics Web site and platform, 02/12:96
Mediware acquires Transtem cellular therapy software, 02/12:96
NovoPath software receives certification as EHR module, 02/12:96
Siemens sponsors moderated online health care forum, 02/12:96
Benefits of diagramming tools to the clinical laboratory, 03/12:82
CompuGroup Medical introduces cloud-based lab outreach software, 03/12:83
Apollo and Dell partner on clinical multimedia management system, 03/12:83
BD Diagnostics purchases laboratory automation solutions company, 03/12:84
Aspyra selects cloud-based NetSuite for global business management, 03/12:84
Siemens Healthcare automates training program management, 03/12:84
New contract and installation, 03/12:84
With clinical groupware, location and affiliation not an issue, 04/12:89
Psyche Systems and Aperio announce integrated AP system, 04/12:90
Voicebrook and Nuance collaborate on speech-enabled reporting products, 04/12:90
Mitem releases communications service for smartphones, 04/12:90
Data Innovations updates method evaluation software, 04/12:90
LIS from SCC Soft Computer certified as EHR module, 04/12:90
In selecting LIS, laboratories left out of the loop, 05/12:81
Siemens and Psyche forge partnership for anatomic pathology system, 05/12:81
Sysmex America debuts second middleware offering, 05/12:81
Psyche Systems introduces microbiology solution, 05/12:81
Aspyra releases latest version of laboratory information system, 05/12:81
Sunquest marketing new release of point-of-care product, 05/12:81
PathCentral sells system to University of Southern California, 05/12:81
More than one promoter of connectivity product, 06/12:94
3M releasing health care data dictionary as open-source software, 06/12:95
New cloud-based service for whole slide images, 06/12:96
Lifepoint Informatics offering laboratory order-entry solution, 06/12:96
Siemens Healthcare enhances data-management system, 06/12:96
NovoPath smartphone app provides anatomic pathology report delivery, 06/12:96
Biometric products finding a home in health care, 07/12:118
Web site focuses on health information laws, 07/12:119
Siemens Healthcare upgrades data-management system, 07/12:119
Federal government posts health care security guide, 07/12:119
Data Innovations releases new version of middleware, 07/12:119
New connectivity standards all about ability to plug and play, 08/12:90
Roper Industries announces purchase of Sunquest Information Systems, 08/12:91
New guidelines on electronic laboratory results reporting, 08/12:91
Zebra acquires LaserBand, 08/12:91
HIMSS offers ICD-10 calculator for assessing financial risk, 08/12:91
Packing up, moving out, settling in: one lab’s relocation, 09/12:91
Mediware Information Systems purchases Strategic Healthcare Group, 09/12:93
SCC lab system receives certification as EHR module, 09/12:93
AHIMA launches tool for mapping HIM careers, 09/12:93
Contracts and installations, 09/12:93
A long haul but LOINC on the leaderboard, 10/12:97
Private equity firm to purchase Mediware, 10/12:98
Orchard introduces software for orders and results management, 10/12:98
McKesson to market NovoPath AP system, 10/12:98
AP-Visions debuts software for specialty physician offices, 10/12:98
Data Innovations updates method-evaluation software, 10/12:98
Giving the laboratory a voice in systemwide informatics strategizing, 11/12:76
Halfpenny Technologies introduces stage two meaningful use tool kit, 11/12:76
Mediware blood-management software receives updated FDA clearance, 11/12:76
4medica offers LOINC mapping, 11/12:76
Ignis Systems’ lab orders and results functionality focus of partnerships, 11/12:77
Brunston system selected by Midwest facilities, 11/12:77
VUHID validated, but patient identification system progressing slowly, 12/12:71
ONC to survey labs about electronic exchange of health information, 12/12:71
Room4 broadens access to mobile app for viewing pathology slides, 12/12:71
Wolters Kluwer Health announces purchase of Health Language, 12/12:71
HL7 to offer free license for standards and other property, 12/12:71
National reference laboratory expands use of Viewics Health Insighter products, 12/12:72

Next-generation sequencing/Sanger sequencing
CAP leads way with next-gen checklist, 08/12:1
Finding a clinical fit for next-gen sequencing, 09/12:1

Obituary
In Memoriam—Loyd R. Wagner, MD, 1926-2012, 05/12:8
In Memoriam—William L. Roberts, MD, PhD, 1960-2012, 10/12:90
In Memoriam—Jeffrey A. Kant, MD, PhD, 1946-2012, 11/12:6

Paraneoplastic syndromes
With paraneoplastic syndromes, big riddle from hidden tumors, 05/12:1

Pathologists/pathology abroad (see also Volunteer/charity work)
Accreditation beyond U.S.? ‘Nothing impossible’ about it, 12/12:46

Patient consults
Providing consults in support of the pain service, 01/12:66

Patient ID systems/patient safety
From bottom to top, a culture of safety, 03/12:1
Positive patient ID: party of one or more?, 07/12:1

Payment issues
Negotiating TC payment in wake of grandfather vote, 07/12:88

Personal genomics (see Genomics)

Personalized medicine/testing
Two for the road with companion diagnostics, 04/12:1

Pharmaceuticals
Warfarin pharmacogenetics a waiting game, 05/12:1

Pharmacogenetics
Warfarin pharmacogenetics a waiting game, 05/12:1

Physician quality reporting system
88305 TC cut, molecular code decision, PQRS details, 11/12:3
Participate in 2013 or prep for 2015 penalty, 12/12:60

Point-of-care testing/guidelines/standards
Thinking big, building small: mini POC DNA device, 08/12:5

Positive patient identification
Tightening the reins on positive patient ID, 07/12:98

Pregnancy testing
Not so obvious—ifs, whens, hows of hCG testing, 06/12:26

Proficiency testing
For new analytes, expanded PT exchange, 05/12:66

Put it on the Board
Baldrige quality honor for Henry Ford, 01/12:90
‘A step toward integrated diagnostics’, 01/12:90
Referral of proficiency testing samples—laboratory wins administrative appeal, 01/12:89
FDA approves Cervista automation, 01/12:89
CLIA waiver for rapid HCV test, 01/12:89
Pertuzumab for HER2-positive metastatic breast cancer, 01/12:89
Honing P. aeruginosa therapy, 02/12:110
Biomarker data released for Alzheimer’s disease, 02/12:110
Physicians, patients, and lab test results, 02/12:109
Nanosphere staph test cleared, 02/12:109
Affymetrix acquires eBioscience, 02/12:109
Gonococcal infections and laboratory capacity for culture, AST, 03/12:98
Product label change for Tysabri includes anti-JCV antibody status, 03/12:98
AACC names Vukovljak EVP, 03/12:98
Ambry reports exome test results, 03/12:98
Needlestick safety—before and after preventive legislation, 03/12:98
Keep your staff happy, 04/12:106
Digital pathology—what’s standing in its way?, 04/12:106
Better infection control in hospitals, 04/12:106
GeneWeave secures funds for molecular platform, 04/12:106
5-, 10-year survival gains for children with ALL, 04/12:106
A ‘points to consider’ policy on genomic sequencing, 05/12:90
New Quest CEO, 05/12:90
GE Healthcare acquires SeqWright, 05/12:90
ACOs and antitrust risk, 05/12:90
Hiring, hours worked, and more, 05/12:90
ACOs and pathologists: a close-up look, 06/12:110
Agilent to acquire Dako, 06/12:110
Tool prompts a rethinking of the CT scan order, 06/12:110
Molecular subtype of prostate cancer reported, 06/12:110
Transgenomic launches gene test technology, 07/12:130
With pertuzumab, more time for breast cancer patients, 07/12:130
Clarient licenses ALK biomarker from Insight, 07/12:130
Melanoma signatures at center of HTG, JWCI union, 07/12:130
FDA OKs Beckman Coulter’s Prostate Health Index, 08/12:102
MDxHealth, Merck expand glioblastoma drug-test deal, 08/12:102
European partners create IT tool to fight antibiotic resistance, 09/12:106
Appeals court again upholds gene patents, 09/12:106
Idaho Technology now BioFire, new FilmArray panels in pipeline, 09/12:106
Leica Biosystems to acquire Aperio, 09/12:106
Webinars on phlebotomy best practices, 09/12:106
For biospecimen management, NovoPath biobank software, 10/12:110
FDA clears GenMark’s RVP, 10/12:110
Beckman to acquire Iris, 10/12:110
AdvanDx launches QuickFISH, 10/12:109
Roche introduces CMV viral load test, 10/12:109
FDA clears Meridian’s group A strep test, 10/12:109
In Cleveland Clinic’s top 10 innovations: mass spec for bacterial ID, 11/12:90
Life Tech cancer panels to be paired with CollabRx interpretive analytics, 11/12:90
Quest to buy UMass outreach lab, 11/12:90
NCI awards grant to PrimeraDx to develop B-cell lymphoma panel, 11/12:90
CellaVision, Siemens reach deal for digital microscopy hematology solutions, 11/12:90
Assay identifies patients at high risk despite small, node-neg lung tumors, 12/12:82
Supreme Court to hear gene patent case, 12/12:82
UPMC to invest $100 million in data warehouse and analytics, 12:12/82
Policy and preventable infection, 12/12:82
FDA clears Nanosphere’s CYP2C19 test, 12/12:82

Q&A
Requirement for manual body fluid cell counting and the various ways it can be done (Galagan), 01/12:80
Guidelines for setting up autovalidation criteria (Lum), 01/12:80
Using MUM1 and CD138 immunohistochemical and kappa and lambda light chain ISH stains for evaluating plasma cell dyscrasias (Alsabeh), 02/12:98
Necessity of changes in the APTT therapeutic range (Higgins, Hollensead), 02/12:98
Is hemodilution a legitimate explanation for an aberrantly low hematocrit? (Young), 03/12:84
If the serum cystatin C is elevated, is there a scale that can be used to correlate that value with an estimate of residual renal function? (Miller), 03/12:85
Is it appropriate for me to refuse to perform frozen sections of a potential donor liver for transplantation? (Talmon), 03/12:85
What is the acceptable percent range of discrepancy among laboratories for flow cytometric analysis? (Davis), 04/12:91
What are the steps for setting up image analysis for quantification of ER, PR, and HER2/neu immunohistochemistry? (Alsabeh), 04/12:94
When faced with double mastectomy or a single mastectomy in which the opposite arm is not a viable arm for phlebotomy, can we draw from a mastectomy arm? (Kuerer), 05/12:80
Is there a good way to estimate the number of fulltime histotechs needed for a histopathology section in a mid-size tertiary hospital with pediatric and adult hemato-oncology/neurosurgery/transplant/renal services? (Kohl), 05/12:80
Is it appropriate to draw a specimen for the prostate-specific antigen test immediately after a digital rectal exam has been performed? (Faix), 05/12:80
Can endometrial hyperplasia be diagnosed in secretory phase endometrium? (Simon), 06/12:97
When performing body fluid cell counts on a hemocytometer, what are acceptable limits of agreement between the two sides? (Galagan), 06/12:98
Is there any protocol for reference ranges for transgender populations? (Wu), 06/12:98
What should the CLS practitioner call hyperclumped pelgeroid neutrophils that are non-segmented? (Galagan), 07/12:116
Why is it that assessment of the FLT3 mutation by PCR cannot be performed on formalin-fixed, paraffin-embedded tissue? (Chang), 07/12:116
Why does the CAP not encourage otolaryngologists and dentists to screen high-risk patients for oral cancer precursors? (Beasley), 07/12:116
What are the best immunohistochemical markers to distinguish squamous cell carcinoma from adenocarcinoma in the lung? (Gown), 08/12:89
What is the standard of practice for confirmation testing with Acetest tablets? (Bock), 08/12:89
Why should we report MCH? (Keren), 09/12:90
Using POC instrument INR for patients not stabilized on warfarin therapy (Perry), 09/12:90
When a patient sample has a result that exceeds the analytic measurement range of an instrument, what is the recommended maximum dilution for the patient sample? (Alter), 09/12:90
Are there special considerations for assays to test for mismatch repair proteins (Lynch syndrome)? (Troxell), 10/12:96
Use of p40 in the panel of antibodies to distinguish adenocarcinoma from squamous cell carcinoma (Gown), 10/12:96
What clinical laboratory thyroid tests in addition to TSH would be necessary to monitor subclinical hyperthyroidism in a patient on methimazole therapy? (Faix), 10/12:97
Is it necessary to heat the slide for vaginal KOH preps? Does the lab need to report out all cellular elements and amine odor? (Wu), 11/12:75
Is it acceptable to perform “mammography” on a breast specimen? (Simpson), 11/12:75
If we add pH eye fluid testing at our facility, will we need to add a set of controls that have the same matrix as the eye fluid even if the urine controls we use cover the range of the eye fluid? (Perry), 11/12:75
Under what circumstances do I have to run negative controls in immunohistochemistry? (Fulton), 12/12:72
Under what conditions would a patient have a normal RBC count but a low hemoglobin and hematocrit? (George), 12/12:72

Quality control/quality improvement
From bottom to top, a culture of safety, 03/12:1

Q-Probes
Bringing down defects in surgical pathology reports, 05/12:3
Specimen rejection: What price for patient care? 07/12:5
In RN Q-Probes, no room for complacency, 11/12:54
On complex surg path, how do lab TATs compare?, 12/12:5

Radiology (see Co-mingling of radiology and pathology)

Rapid testing
Thinking big, building small: mini POC DNA device, 08/12:5

Reference lab testing services/send-out testing
The sense and cents of send-outs, 02/12:1

Respiratory viruses/treatments
For respiratory virus detection, a golden age, 04/12:1

Safety (See also Patient ID systems/Patient safety)
From bottom to top, a culture of safety, 03/12:1

Screening tests
Not so obvious—ifs, whens, hows of hCG testing, 06/12:26

Self-referrals
GAO: With self-referral, CT, MRI volumes soar, 12/12:1

Self-testing (see Point-of-care testing)

Send-out testing
For slimmed-down send-outs, data in the driver’s seat, 03/12:36

Shorts on Standards
Are those platelets safe? 04/12:40
Biomarkers Consortium and next-gen sequencing, 08/12:34

Software (see Information systems, software technologies)
Here and now, business software tracks lab labors, 06/12:3

Specimen collection/ labeling/processing/rejection
Specimen rejection: What price for patient care?, 07/12:5
Small start, then big drop in specimen labeling errors, 07/12:107

Surgical pathology reports
Bringing down defects in surgical pathology reports, 05/12:3

System review series (see Information systems, software technologies)

Test standardization
Creating harmony, step by uncommon step, 08/12:1

Thyroid disease/testing
New attention settling on genomic thyroid nodule test, 11/12:39

Toxicology testing
Tricks and traps of testing for benzos and barbs, 02/12:64

Transfusions (see Blood banking/transfusions)

Transplantation
Lowering infectious disease risks for transplants, 10/12:32

Transplant services

Troponin
To see troponin’s future, look at the present, 07/12:1

Turnaround time
On complex surg path, how do lab TATs compare? 12/12:5

Unnecessary testing
Lab teams up to curb unneeded testing, 12/12:1

Warfarin
Warfarin pharmacogenetics a waiting game, 05/12:1

 

Related Links Related Links

       
 
 © 2014 College of American Pathologists. All rights reserved. | Terms and Conditions | CAP ConnectFollow Us on FacebookFollow Us on LinkedInFollow Us on TwitterFollow Us on YouTubeFollow Us on FlickrSubscribe to a CAP RSS Feed